Assoc Director, Global Software Product Marketing, Oncology, Genetic & Rare Disease Testing at Illumina
Check out this engaging Mendelspod podcast discussion between Samuel Strom, PhD FACMG and Theral Timpson on #raredisease and other #hereditary disease testing, focusing in on Illumina’s commitment to making workflows highly accessible and scalable through integrated bioinformatic solutions— #DRAGEN secondary analysis for variant calling and #Emedgene for variant interpretation through research reporting. And if you’re attending #ACMGMtg24, Sam and our team around all Illumina solutions, including DRAGEN and Emedgene, will be there! DM to coordinate - I hope to see you there! #clinicaltesting #clinicalgenomics #bioinformatics #artificialintelligence #automation
Principal Scientist at Illumina, Samuel Strom, PhD FACMG, takes us inside the company's new push to improve variant calling and genome interpretation. He envisions "lights out" testing that could really help democratize clinical genetics. https://lnkd.in/gNHXf-_3
Associate Director of Product Management at Illumina
3moLoved this conversation!